Inventor · disambiguated record
Ge Peng
Also filed as: PENG GE
26 granted patents·7 pending applications·410 citations·filing 2001–2022
96Inventor score
Top patents by PatentIndex Score
33 records- 0197US7511158B2Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofXENOPORT INC·Filed 2007·Granted Mar 31, 2009·29 cites·32 claims
- 0296US7227028B2Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofXENOPORT INC·Filed 2004·Granted Jun 5, 2007·93 cites·84 claims
- 0395US7749985B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2009·Granted Jul 6, 2010·28 cites·21 claims
- 0495US7109239B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2004·Granted Sep 19, 2006·61 cites·25 claims
- 0594US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 0694US8344028B2Gamma-amino-butyric acid derivatives as GABAB receptor ligandsXENOPORT INC·Filed 2010·Granted Jan 1, 2013·43 cites·28 claims
- 0794US7300956B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2006·Granted Nov 27, 2007·25 cites·8 claims
- 0894US7265096B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2003·Granted Sep 4, 2007·62 cites·83 claims
- 0993US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 1091US8003809B2Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofXENOPORT INC·Filed 2009·Granted Aug 23, 2011·6 cites·9 claims
- 1190US8378137B2Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofXENOPORT INC·Filed 2011·Granted Feb 19, 2013·5 cites·25 claims
- 1288US7803785B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2009·Granted Sep 28, 2010·13 cites·18 claims
- 1387US7572830B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2007·Granted Aug 11, 2009·7 cites·25 claims
- 1486US10675353B2Pegylated carfilzomib compoundsAMGEN INC·Filed 2019·Granted Jun 9, 2020·2 cites·25 claims
- 1584US7608602B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2007·Granted Oct 27, 2009·6 cites·31 claims
- 1682US9315542B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·4 cites·30 claims
- 1781US8062870B2Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugsGALLOP MARK A·Filed 2009·Granted Nov 22, 2011·5 cites·16 claims
- 1878US10517954B2Pegylated carfilzomib compoundsAMGEN INC·Filed 2017·Granted Dec 31, 2019·2 cites·23 claims
- 1977US9944592B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2016·Granted Apr 17, 2018·1 cites·16 claims
- 2076US9309283B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Apr 12, 2016·2 cites·54 claims
- 2176US7585996B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2007·Granted Sep 8, 2009·2 cites·27 claims
- 2268US2009234138A1Acyloxyalkyl carbamate prodrugs, methodsGALLOP MARK A·Filed 2009·Application pending·0 cites
- 2366US11077198B2Pegylated carfilzomib compoundsAMGEN INC·Filed 2020·Granted Aug 3, 2021·0 cites·25 claims
- 2466US10385014B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Aug 20, 2019·0 cites·11 claims
- 2564US10682419B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2018·Granted Jun 16, 2020·0 cites·19 claims
- 2664US9353057B2Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereofXENOPORT INC·Filed 2013·Granted May 31, 2016·0 cites·12 claims
- 2758US2023158151A1Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2857US2024279202A1Compounds for inhibiting or degrading itk, compositions, comprising the same methods of their making and methods of their useNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2956US9878047B2Prodrugs of peptide epoxy ketone protease inhibitorsONYX THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·0 cites·13 claims
- 3056US2025002489A1Bifunctional compounds for degrading itk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3156US2011021571A1Acyloxyalkyl carbamate prodrugs, methods of synthesis and useXENOPORT INC·Filed 2010·Application pending·0 cites
- 3244US2023024442A1Bifunctional compounds for grading btk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3344US2002065309A1Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonistsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ge Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →